US regulatory status: approved. Mechanism: Supplement.
- Mechanism
- Supplement
pharma · Iron Deficiency
Vifor Fresenius Medical Care Renal Pharma France
Fresenius Medical Care drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Fresenius Medical Care drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
US regulatory status: approved. Mechanism: Supplement.
US regulatory status: approved. Mechanism: Supplement.